<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 29 Jan 2021 21:00:58 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>抗体药物动态-20210129</title><link>https://mp.weixin.qq.com/s/jHGxwAUJHHu1V_qAtmt_oQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210129]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:56:48 +0800</pubDate></item><item><title>常见非IgG样双抗</title><link>https://mp.weixin.qq.com/s/-AFCnGiU4lLjNossw7Xlfg</link><description></description><content:encoded><![CDATA[常见非IgG样双抗]]></content:encoded><pubDate>Thu, 28 Jan 2021 18:11:02 +0800</pubDate></item><item><title>抗体药物动态-20210128</title><link>https://mp.weixin.qq.com/s/v1qFjVFLzHsa_vNQdoF2VA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210128]]></content:encoded><pubDate>Thu, 28 Jan 2021 18:11:02 +0800</pubDate></item><item><title>是否打疫苗？打了疫苗后就不会得新冠了吗？</title><link>https://mp.weixin.qq.com/s/6gSc9i9lSgUVBqjShdLMvw</link><description></description><content:encoded><![CDATA[是否打疫苗？打了疫苗后就不会得新冠了吗？]]></content:encoded><pubDate>Wed, 27 Jan 2021 18:15:14 +0800</pubDate></item><item><title>IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景</title><link>https://mp.weixin.qq.com/s/QPhCL_vMYivu47UijAKctw</link><description></description><content:encoded><![CDATA[IL-2和IL-15的肿瘤免疫中的调节作用及其应用前景]]></content:encoded><pubDate>Tue, 26 Jan 2021 18:29:09 +0800</pubDate></item><item><title>抗体药物动态-20210126</title><link>https://mp.weixin.qq.com/s/ec_RZIyZjgL0QQw6kARbjw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210126]]></content:encoded><pubDate>Tue, 26 Jan 2021 18:29:09 +0800</pubDate></item><item><title>“生物导弹”ADC 药物迎来黄金时代，挑战下一个千亿市场！</title><link>https://mp.weixin.qq.com/s/SuOErnn7nkw60f4_IctbAA</link><description></description><content:encoded><![CDATA[“生物导弹”ADC 药物迎来黄金时代，挑战下一个千亿市场！]]></content:encoded><pubDate>Mon, 25 Jan 2021 18:31:25 +0800</pubDate></item><item><title>靶向新生儿Fc受体：FcRn</title><link>https://mp.weixin.qq.com/s/0P054Crl1VSw9Rhn_dHN1g</link><description></description><content:encoded><![CDATA[靶向新生儿Fc受体：FcRn]]></content:encoded><pubDate>Fri, 22 Jan 2021 18:41:03 +0800</pubDate></item><item><title>抗体药物动态-20210122</title><link>https://mp.weixin.qq.com/s/9ngqBUUHzlTiwirXXtS2Fg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210122]]></content:encoded><pubDate>Fri, 22 Jan 2021 18:41:03 +0800</pubDate></item><item><title>国家卫健委官宣: 返乡人员需持7日以内核酸检测阴性证明</title><link>https://mp.weixin.qq.com/s/M584WhWuYFTt-NUDkB2D5Q</link><description></description><content:encoded><![CDATA[国家卫健委官宣: 返乡人员需持7日以内核酸检测阴性证明]]></content:encoded><pubDate>Thu, 21 Jan 2021 02:02:14 +0800</pubDate></item><item><title>抗体药物动态-20210120</title><link>https://mp.weixin.qq.com/s/9NvFi_xIK0OvKD1d_Qu47g</link><description></description><content:encoded><![CDATA[抗体药物动态-20210120]]></content:encoded><pubDate>Wed, 20 Jan 2021 18:48:22 +0800</pubDate></item><item><title>抗体药物的免疫原性</title><link>https://mp.weixin.qq.com/s/qSofY2kDRnecwbVrhV9Dqg</link><description></description><content:encoded><![CDATA[抗体药物的免疫原性]]></content:encoded><pubDate>Mon, 18 Jan 2021 18:34:46 +0800</pubDate></item><item><title>抗体药物动态-20210118</title><link>https://mp.weixin.qq.com/s/ivPHPikA3a-m-9k19_h3qw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210118]]></content:encoded><pubDate>Mon, 18 Jan 2021 18:34:46 +0800</pubDate></item><item><title>抗体药物动态-20210114</title><link>https://mp.weixin.qq.com/s/fYqgThDOEmtupBZ5iOTcbw</link><description></description><content:encoded><![CDATA[抗体药物动态-20210114]]></content:encoded><pubDate>Thu, 14 Jan 2021 18:52:48 +0800</pubDate></item></channel></rss>